Uses
TRYPTYR is indicated for the treatment of the signs and symptoms of dry eye disease. TRYPTYR is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease.
Source: US FDA prescribing information
Molecule
Acoltremon is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease. It is available as ophthalmic solution for topical use. MedsAcross supplies Acoltremon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
TRYPTYR is indicated for the treatment of the signs and symptoms of dry eye disease. TRYPTYR is a TRPM8 thermoreceptor agonist indicated for the treatment of the signs and symptoms of dry eye disease.
Source: US FDA prescribing information
Studies in animals suggest that acoltremon, the active substance in TRYPTYR, is an agonist of transient receptor potential melastatin 8 (TRPM8) thermoreceptors. TRPM8 thermoreceptor stimulation has been shown to activate trigeminal nerve signaling leading to increased basal tear production. The exact mechanism of action for TRYPTYR in dry eye disease is unknown.
Source: US FDA prescribing information
Instill one drop in each eye twice daily (approximately 12 hours apart). Recommended Dosage Instill one drop in each eye twice daily (approximately 12 hours apart).
Source: US FDA prescribing information
None. None.
Source: US FDA prescribing information
To avoid the potential for eye injury and contamination, do not touch the vial tip to the eye or other surfaces. Potential for Eye Injury and Contamination To avoid the potential for eye injury and contamination, do not touch the vial tip to the eye or other surfaces. Use with Contact Lenses TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration of TRYPTYR.
Source: US FDA prescribing information
The most common adverse reaction was instillation site pain (50%).
Source: US FDA prescribing information
Storage Store refrigerated at 2°C to 8°C (36°F to 46°F). If stored at room temperature, TRYPTYR should be used within 30 days, not to exceed the expiration date printed on the carton and foil pouch. After opening the carton, TRYPTYR may be stored refrigerated or at room temperature at 2°C to 25°C (36°F to 77°F). Store unopened single-dose vials in the original foil pouch until ready to use.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Acoltremon, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tryptyr 0.03 mg/mL ophthalmic solutionOphthalmic, topical Cold chain | Alcon Laboratories | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 28 May 2025 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 1 presentations of Acoltremon and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Acoltremon, including Tryptyr.
Yes. The US FDA first approved Acoltremon on 28 May 2025, according to Drugs@FDA.
At least one listed presentation of Acoltremon must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.